|
| 37647861 | Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors. | J Clin Endocrinol Metab | 2024 |
| 37534915 | Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma. | | 2023 |
| 36807339 | Genomic ALK alterations in primary and relapsed neuroblastoma. | Br J Cancer | 2023 |
| 35152459 | Confirmatory adaptive group sequential designs for single-arm phase II studies with multiple time-to-event endpoints. | Biometrical Journal | 2022 |
| 34569150 | Hypercalcemia is a frequent side effect of 13-cis-retinoic acid treatment in patients with high-risk neuroblastoma. | Pediatric Blood and Cancer | 2022 |
| 34503173 | Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> Amplification. | Cancers (Basel) | 2021 |
| 34240006 | Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial. | JNCI Cancer Spectrum | 2021 |
| 33826231 | Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18Â months without MYCN amplification. | Pediatr Blood Cancer | 2021 |
| 33205902 | A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project. | Pediatr Blood Cancer | 2021 |
| 33245195 | The reliability of bone marrow cytology as response criterion in metastatic neuroblastoma. | Pediatr Blood Cancer | 2021 |
| 32869227 | [Quadruple negative SARS-CoV-2-PCR: still COVID-19 pneumonia!] | Deutsche Medizinische Wochenschrift | 2020 |
| 32067684 | Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. | Ann Oncol | 2020 |
| 31724812 | Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine. | Pediatric Blood and Cancer | 2020 |
| 32472746 | The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. | Pediatr Blood Cancer | 2020 |
| 32466789 | Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure. | BMC Pharmacol Toxicol | 2020 |
| 30848089 | From a single meeting to a scientific community: Quantification of the "Advances in Neuroblastoma Research Association" network. | Pediatric Blood and Cancer | 2019 |
| 31631570 | A new risk score for patients after first recurrence of stage 4 neuroblastoma aged â¿¥18Â months at first diagnosis. | Cancer Med | 2019 |
| 31551583 | Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. | British Journal of Cancer | 2019 |
| 35100718 | Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma. | JCO Precis Oncol | 2019 |
| 30262570 | THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. | Haematologica | 2019 |
| 30682100 | Are network growth and the contributions to congresses associated with publication success? A pediatric oncology model. | PLoS ONE | 2019 |
| 30518699 | Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients. | JCI Insight | 2018 |
| 29021103 | Retrospective analysis of relapsed abdominal high-risk neuroblastoma. | Journal of Pediatric Surgery | 2018 |
| 29925908 | Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. | Leukemia | 2018 |
| 30523111 | A mechanistic classification of clinical phenotypes in neuroblastoma. | Science | 2018 |
| 29991700 | Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. | British Journal of Cancer | 2018 |
| 27984660 | Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. | Cancer | 2017 |
| 28604107 | Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. | Expert Opin Drug Discov | 2017 |
| 28840597 | Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. | | 2017 |
| 28329731 | Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients. | European Journal of Cancer | 2017 |
| 28786082 | Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015. | Paediatric Drugs | 2017 |
| 28778185 | Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18Â months. | BMC Cancer | 2017 |
| 28561228 | 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. | Klin Padiatr | 2017 |
| 28561225 | Feasibility, Risk Profile and Diagnostic Yield of Stereotactic Biopsy in Children and Young Adults with Brain Lesions. | Klinische Padiatrie | 2017 |
| 28471719 | Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. | J Clin Oncol | 2017 |
| 29091799 | Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment. | Neoplasia | 2017 |
| 29149133 | Computer-Based Exercise Program: Effects of a 12-Week Intervention on Mood and Fatigue in Pediatric Patients With Cancerâ¿©. | Clinical Journal of Oncology Nursing | 2017 |
| 29148865 | Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma. | Pediatric Hematology and Oncology | 2017 |
| 27654028 | Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence. | Pediatric Blood and Cancer | 2017 |
| 27588497 | γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets. | Oncotarget | 2016 |
| 27383785 | Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. | Nature | 2016 |
| 27011226 | Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review. | Klinische Padiatrie | 2016 |
| 26796600 | Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. | European Journal of Cancer | 2016 |
| 27043079 | Rapid COJEC Induction Therapy for High-risk Neuroblastoma Patients - Cochrane Review. | Klinische Padiatrie | 2016 |
| 27465021 | Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed. | BMC Cancer | 2016 |
| 26223516 | Correction factors for self-selection when evaluating screening programmes. | Journal of Medical Screening | 2016 |
| 26598443 | Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma. | Mol Oncol | 2016 |
| 26541336 | Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children. | Strahlentherapie und Onkologie | 2016 |
| 25204374 | Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial. | Leuk Lymphoma | 2015 |
| 25634649 | Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation. | | 2015 |